VACH SEC Filings - Voyager Acquisition Corp 10-K, 10-Q, 8-K Forms

NodeGuardian · 2026-04-01T18:45:36+00:00

The page offers a resource for Voyager Acquisition Corp. SEC filings, highlighting a merger consideration increase to $1.35 billion with Veraxa Biotech AG, sponsor equity changes, and a merger deadline extension to August 2026, along with AI-based analysis.

NodeGuardian

2026-04-01 18:45:36

Abstract generation in progress

This page provides a comprehensive resource for Voyager Acquisition Corp. (VACH) SEC filings, including annual, quarterly, and material event reports, with analysis from Rhea-AI. Recent filings indicate an increase in the planned merger consideration with Veraxa Biotech AG to $1.35 billion, a change in sponsor equity, and an extension of the merger agreement deadline to August 7, 2026. The platform also offers AI-generated summaries, sentiment and impact scores, and end-of-day stock performance data for each filing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes